HRS4R
Vull donar
Firma
OLGA TURA-CEIDE
Posició
Cap de Grup - R4
Caps de Grup - R4

Projectes

Codi oficial: PI21/01212- SIENA Data inici: 01/01/2022 Data fi: 30/06/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: CPII22/00006 Data inici: 01/06/2023 Data fi: 31/05/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: FI22/00133 Miriam Peracaula Data inici: 16/01/2023 Data fi: 31/10/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: 202336-30 Data inici: 22/04/2024 Data fi: 21/04/2027 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: FUNDACIO LA MARATO TV3
Codi oficial: 2023_SEC_OTC Data inici: 16/06/2023 Data fi: 31/12/2027 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: SOCIEDAD ESPAÑOLA DE CARDIOLOGIA
Codi oficial: CNS2023-145362 Data inici: 01/04/2024 Data fi: 30/06/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: MINISTERIO DE ECONOMIA E INNOVACION
Codi oficial: GLD24/00100 Data inici: 01/01/2025 Data fi: 01/12/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: GILEAD SCIENCES, S.L.U
Codi oficial: 2024_ACM_OTC Data inici: 01/03/2023 Data fi: 01/03/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: FUNDACIÓ ACADÈMIA CIÈNCIES MÈDIQUES
Codi oficial: PID2024-158803OB-I00 Data inici: 01/09/2025 Data fi: 31/08/2028 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: MINISTERIO DE ECONOMIA E INNOVACION
Codi oficial: FPU24/01802 Data inici: 01/12/2025 Data fi: 31/10/2029 Investigador/a principal: OLGA TURA CEIDE, MARIA PUGIBET CAMARILLAS Organisme finançador: MINISTERIO DE ECONOMIA E INNOVACION
Codi oficial: 2025 STEP 00048 Data inici: 01/11/2025 Data fi: 31/10/2028 Investigador/a principal: OLGA TURA CEIDE, MARIA PUGIBET CAMARILLAS Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA

Publicacions

Ayyoub S, Dhillon NK, Tura-Ceide O

Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms.

Infectious Disease Reports, 2025, 17 dx.doi.org/10.3390/idr17010015
POYATOS DORADO, PAULA, GRATACÓS AURICH, MIQUEL, AYYOUB, SANA, TURA CEIDE, OLGA

Chapter 18 - Vascular manifestations of COVID-19: Endothelial dysfunction and damage

Understanding the Pandemic: Pathophysiology, Transmission and Treatment of COVID-19, 2025, 323-334 dx.doi.org/10.1016/B978-0-443-19170-1.00034-6
Tura-Ceide O, Oto J, Osorio J, Hervás D, Peinado VI, Sánchez-López V, Arellano E, Gratacós M, Bonjoch C, Torralba Y, Blanco I, Medina P, Otero R, Barberà JA

The Potential of Extracellular Microvesicle-microRNAs in Precapillary Pulmonary Hypertension.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2025, 73, 147-151 dx.doi.org/10.1165/rcmb.2024-0282LE
Blanco, I, Casós, K, Gómez-Hernández, I, Armora, AB, Sardiné, A, Tura-Ceide, O, Fernández-Hernández, R, Barbera, JA, Peinado, VI

Effects of Physical Training on Mitochondrial Dynamic in Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2025, 211 dx.doi.org/10.1164/ajrccm.2025.211.Abstracts.A2445
Blanco, I, Aguilar, D, Casós, K, Gómez-Hernández, I, Tura-Ceide, O, Serrano-Mollar, A, Barbera, JA, Peinado, VI

Effects of Low-intensity Exercise on Pulmonary Arterial Hypertension: A Comprehensive Transcriptomic Analysis of Lung, Heart and Muscle

American journal of respiratory and critical care medicine, 2025, 211 dx.doi.org/10.1164/ajrccm.2025.211.Abstracts.A2444
Sardiné, A, Fernández-Hernández, R, Colindres, RA, Valle, YR, Armora, AB, Ramirez, A, Rosado, A, Benguría, A, Dopazo, A, Peinado, VI, Blanco, I, Tura-Ceide, O, Barbera, JA

Functional Characterization of Pulmonary Endothelial Cells Harvested From Pulmonary Artery Catheter in Pulmonary Arterial Hypertension: Effect of Treatment

American journal of respiratory and critical care medicine, 2025, 211 dx.doi.org/10.1164/ajrccm.2025.211.Abstracts.A2443
Poyatos P, Peinado VI, Blanco I, Osorio J, Yuan S, Ramírez AM, Castellà M, Rigol M, Solanes N, Straub AC, Barberà JA, Tura-Ceide O

Assessing the role of endothelium-protective drugs: Functional and molecular insights into chronic thromboembolic pulmonary hypertension derived endothelial cells.

BIOMEDICINE & PHARMACOTHERAPY, 2025, 190, 118425-118425 dx.doi.org/10.1016/j.biopha.2025.118425
Nicoleau, S, Valle, YR, Tura-Ceide, O, Armour, CH, Barberà, JA, McKinnon, TAJ, Gopalan, D, Wojciak-Stothard, B

3D modelling of pulmonary arterial stenosis and endothelial dysfunction in CTEPH

LAB ON A CHIP, 2025, 25, 4369-4384 dx.doi.org/10.1039/d5lc00300h
Poyatos P, Luque N, Sabater G, Eizaguirre S, Bonnin M, Orriols R, Tura-Ceide O

Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6-and 12-months SARS-CoV-2 infection

Infection, 2024, 52, 1269-1285 dx.doi.org/10.1007/s15010-024-02173-5
Peracaula, M, Martinez-Blanco, A, Gavara, N, Gratacos, M, Peinado, V, Blanco,, Barbera, JA, Tura-Ceide, O

Endothelial cells in chronic thromboembolic pulmonary hypertension exhibit cytoskeletal alteration

CARDIOVASCULAR RESEARCH, 2024, 120 dx.doi.org/10.1093/cvr/cvae088.184

Formulari de contacte

Coneix l’IDIBGI!

menu